Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SynektikWAR:SNT -0.39%89 Days Payable is 88.29 as of Jun. 2026, which is 26% below its 10-year median of 119.87. GuruFocus rates WAR:SNT with a GF Score™ of 89/100 and a GF Value™ of zł292.46 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Synektik ranks better than 66.33% on this metric.
Synektik's average Accounts Payable for the
three
months ended in Jun. 2026 was zł191.3 Mil. Synektik's Cost of Goods Sold for the
three
months ended in Jun. 2026 was zł197.7 Mil.
Hence, Synektik's Days Payable for the
three
months ended in Jun. 2026 was 88.29.
The historical rank and industry rank for Synektik's Days Payable or its related term are showing as below:
WAR:SNT'
s Days Payable Range Over the Past 10 Years
Min: 76.34 Med: 119.87 Max: 208.4
Current: 102.35
During the past 13 years, Synektik's highest Days Payable was 208.40. The lowest was 76.34. And the median was 119.87.
WAR:SNT's Days Payable is ranked better than 66.33% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 68.47
vs WAR:SNT: 102.35
Synektik's Days Payable
declined
from Jun. 2025 (98.52) to Jun. 2026 (88.29).
It may suggest that Synektikaccelerated paying its suppliers.
The historical data trend for Synektik's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Synektik's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synektik Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synektik's Days Payable distribution charts can be found below:
* The bar in red indicates where Synektik's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Synektik's Days Payable for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synektik (WAR:SNT) has a Days Payable of 88.29 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Synektik and its competitors. This is 26% below median its historical median of 119.87. Over the past decade, Synektik's Days Payable has ranged from 76.34 to 208.40. According to the industry distribution chart, Synektik ranks #267 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 33.7%.
Is Synektik's Days Payable too high?
Synektik's current Days Payable of 88.29 is 26% below median its 10-year median of 119.87. Over the past 10 years, this metric has ranged from a low of 76.34 to a high of 208.40. The Medical Devices & Instruments industry median Days Payable is 68.47. Synektik's value of 88.29 is 28.9% above this industry median. Based on the distribution chart, Synektik ranks #267 out of 793 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Synektik has a GF Score™ of 89/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Synektik's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Synektik ranks #267 out of 793 companies for Days Payable. This puts Synektik in the upper half of its industry. The industry median Days Payable is 68.47. Synektik's value of 88.29 is 28.9% above this benchmark. Historically, Synektik's own Days Payable has ranged from 76.34 to 208.40 over the past decade. While the company's 10-year median is 119.87 vs. the industry median of 68.47, Synektik has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.47, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synektik's current Days Payable of 88.29 is 28.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Synektik and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synektik's current Days Payable is 88.29, which is 26% below median its own 10-year median of 119.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synektik stock overvalued right now?
Based on GuruFocus' analysis, Synektik (WAR:SNT) is currently considered Modestly Overvalued. The stock's GF Value™ is zł292.46, compared to a current price of zł355.60 — trading 21.6% above its estimated fair value. The current Days Payable is 88.29, which is 26% below median its 10-year median of 119.87 and 28.9% above the Medical Devices & Instruments industry median of 68.47. Synektik's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Synektik (WAR:SNT), the current Days Payable is 88.29 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synektik (WAR:SNT) Overvalued in 2026?
Based on GuruFocus' analysis, Synektik stock appears to be overvalued.
The current stock price of zł355.60 is trading 21.6% above its estimated GF Value™ of zł292.46.
GuruFocus considers Synektik to be Modestly Overvalued.
Key valuation signals for WAR:SNT:
Days Payable: 88.29 (26% below median its 10-year median of 119.87)
GF Value™: zł292.46 vs. price of zł355.60 (21.6% above fair value)
Industry Position: 28.9% above the Medical Devices & Instruments median (#267 of 793)
No single metric tells the full story. See the WAR:SNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synektik SA is a supplier of innovative products, services and IT solutions for diagnostic imaging and nuclear medicine. It sells medical devices and IT solutions used in radiology and operates research laboratory for diagnostic imaging systems and a service centre for medical equipment. Its operating segments include the sale of medical equipment used in radiology and nuclear medicine and IT solutions, Maintenance services for medical equipment as well as acceptance and specialist tests and Radiopharmaceutical production.
89GF Score
Get the complete analysis for WAR:SNT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SNT has been successfully added to your 
